MedTrace Logo

Sublingual Misoprostol for Induction of Labor

NCT01406392 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-09-18

No results posted yet for this study

Summary

The purpose of this study is to compare effectiveness and safety of a sublingual misoprostol 12,5 mcg with vaginal misoprostol 25 mcg for induction of labour with an alive and term fetus.

Conditions

  • Labor
  • Induced

Interventions

DRUG

Misoprostol 25mcg

Vaginal misoprostol or placebo tablets will be administered for each six hours until the maximum dose of 200mcg or eight tablets.

DRUG

Sublingual Misoprostol

Sublingual misoprostol or placebo tablets will be administered for each six hours until the maximum dose of 100mcg or eight tablets

Sponsors & Collaborators

  • Maternidade Escola Assis Chateaubriand

    collaborator OTHER

  • Professor Fernando Figueira Integral Medicine Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-01
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01406392 on ClinicalTrials.gov